Quarterly report pursuant to Section 13 or 15(d)

Capital Structure - Narrative (Details)

v3.24.2
Capital Structure - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended
Mar. 28, 2024
USD ($)
shares
Mar. 27, 2024
shares
Mar. 31, 2024
USD ($)
class_of_stock
$ / shares
shares
Mar. 31, 2024
USD ($)
class_of_stock
$ / shares
shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
$ / shares
shares
Common Stock Warrants            
Number of classes of stock authorized (in shares) | class_of_stock     2 2    
Number of shares of capital stock authorized to issue (in shares)     205,000,000 205,000,000    
Common stock, shares authorized (in shares)     200,000,000 200,000,000   200,000,000
Temporary equity, shares authorized (in shares)     5,000,000 5,000,000    
Common stock, par value (in dollars per share) | $ / shares     $ 0.001 $ 0.001   $ 0.001
Temporary equity, par value per share (in dollars per share) | $ / shares     $ 0.001 $ 0.001    
Proceeds from sale of shares pursuant to common stock private placement, net | $       $ 115,625 $ 0  
Private placement transaction costs | $       $ 9,220 $ 0  
Temporary equity, shares outstanding (in shares)     22,360 22,360   0
Other Expense            
Common Stock Warrants            
Private placement transaction costs | $       $ 1,700    
Warrant liability | Level 3            
Common Stock Warrants            
Exercise price per share (in dollars per share) | $ / shares     $ 5.796933 $ 5.796933    
Series C Preferred Stock            
Common Stock Warrants            
Temporary equity, shares authorized (in shares)     34,326 34,326   0
Temporary equity, par value per share (in dollars per share) | $ / shares     $ 0.001 $ 0.001   $ 0.001
Temporary equity, shares outstanding (in shares)     22,358 22,358   0
Series D Preferred Stock            
Common Stock Warrants            
Temporary equity, shares authorized (in shares)     1 1   0
Temporary equity, par value per share (in dollars per share) | $ / shares     $ 0.001 $ 0.001   $ 0.001
Temporary equity, shares outstanding (in shares)     1 1   0
Temporary equity, liquidation preference (in dollars per share) | $ / shares     $ 0.001 $ 0.001    
Series E Preferred Stock            
Common Stock Warrants            
Temporary equity, shares authorized (in shares)     1 1   0
Temporary equity, par value per share (in dollars per share) | $ / shares     $ 0.001 $ 0.001   $ 0.001
Temporary equity, shares outstanding (in shares)     1 1   0
Temporary equity, liquidation preference (in dollars per share) | $ / shares     $ 0.001 $ 0.001    
Private Placement            
Common Stock Warrants            
Preferred Stock, convertible, shares issuable in common stock (in shares)   1,000 1,000 1,000    
Net proceeds | $ $ 185,000   $ 185,000      
Proceeds from sale of shares pursuant to common stock private placement, net | $ $ 108,100   108,100      
Transactions costs, percentage of gross proceeds       2.50%    
Private Placement | Other Expense            
Common Stock Warrants            
Private placement transaction costs | $       $ 7,500    
Private Placement | Warrant liability            
Common Stock Warrants            
Sale of stock (in shares) 11,967,526          
Fair value of warrant | $ $ 69,400   69,400 69,400    
Private Placement | Preferred Stock            
Common Stock Warrants            
Net proceeds | $ $ 115,600   $ 115,600      
Private Placement | Series C Preferred Stock            
Common Stock Warrants            
Sale of stock (in shares) 19,946          
AlmataBio Transaction            
Common Stock Warrants            
Common stock shares issued (in shares)   171,605        
Shares issuable in common stock (in shares)   2,412        
AlmataBio Transaction | Series C Preferred Stock            
Common Stock Warrants            
Issuance of Series C Preferred Stock pursuant to Almata Transaction | $       $ 11,457